3206 results about "Mannitol" patented technology

The present invention is sludge curing agent and its application, and belongs to the field of soil treating chemicals technology. The sludge curing agent includes powdered components and liquid components, the powdered components include cement clinker 30-60 weight portions, slag 30-60 weight portions, lime 3-8 weight portions, gypsum 1-7 weight portions and other sulfates 1-7 weight portions; and the liquid components include polyacrylamide 5-30 weight portions, polyaluminum chloride 0-20 weight portions, mannitol 0-30 weight portions, lignosulfonate 20-80 weight portions, lignosulfonate-iron or chromium ion complex 0-30 weight portions, alkylphenol ethoxylate 0.2-2 weight portions, tannin 0-10 weight portions, humate 0-10 weight portions, and alpa-olefin sulfonate 0.2-2.5 weight portions. The sludge curing agent has low cost, small consumption, high cumulate strength and high cumulate water tolerance, and may be applied widely.

The present invention provides a solvent for electronic cigarette liquid, comprising sorbitol. In the present invention, sorbitol is used as the solvent for electronic cigarette liquid. The electronic cigarette liquid which is prepared with the solvent for electronic cigarette liquid provided by the present invention is not greasy and free of miscellaneous taste, and therefore provides relatively higher comfort level during smoking. Further, the electronic cigarette liquid provided by the present invention may further comprise one or more of propylene glycol, glycerol, and mannitol. Due to the effects of propylene glycol, glycerol and mannitol, the sorbitol makes the electronic cigarette liquid which is prepared with the solvent for electronic cigarette liquid provided by the present invention generate a relatively greater amount of smoke, improve the experience of the smoker, and provide a thick and full experience, a smooth mouthfeel without any miscellaneous taste, and a relatively higher comfort level during smoking. Furthermore, all the components in the solvent for electronic cigarette liquid provided by the present invention are of food grade, and are harmless to the body of the smoker.

The present invention provides rapid disintegrating tablets in oral cavity having a shortened disintegration time in oral cavity as well as a sufficient hardness compared to rapid disintegrating tablets of the prior art. The above objective is solved by a composition in which the inorganic excipient and the disintegrating agent are dispersed in the complex particles consisting of mannitol and other saccharide(s) in a specific ratio, and rapid disintegrating tablets in oral cavity obtained by direct compression of the composition.

The invention relates to probiotic microcapsules as well as a preparation method and application thereof. The probiotic microcapsules comprise a core material and a wall material, wherein the core material is probiotics; the outer layer of the wall material is coated with chitosan; the wall material is prepared from an aqueous solution containing a natural polymer material and a freeze-drying protection agent; the freeze-drying protection agent comprises one or more of glucose, fructose, sucrose, lactose, trehalose, soluble starch, glycerin, mannitol, Arabic gum, dextran 40 and skim milk; the natural polymer material comprises one or more of gellan gum, xanthan gum, k-carrageenan, sodium alginate, cellulose acetate phthalate or gelatin; in the aqueous solution, the volume fraction of the freeze-drying protection agent is 4.0%-20.0% and the volume fraction of the polymer material is 0.5%-5.0%. The probiotic microcapsules can keep excellent acid resistance and storage stability before and after being freeze-dried.

Described are flavor composition, flavor component, perfume composition and perfume component-containing microparticles which are particulate matrices composed of:(a) an olfactorily active component (e.g., perfume component);(b) silica; and(c) a saccharide composition which is a mixture of mannitol and maltose.The microparticles are useful in augmenting, enhancing and/or imparting aroma and/or taste (over relatively long periods of time in a controllably releasable manner) to perfume compositions, perfumed articles (e.g., deodorancy and antiperspirant sticks), foodstuffs, chewing gums, beverages and the like. Also described is a process for preparing the above-mentioned microparticles using, in sequence, (1) adsorption of the olfactorily active material onto silica followed by (2) a blending/extrusion step followed by (3) at least one particularization step.

The present invention provides compositions and methods for enhancing the neuroprotective effect of umbilical cord blood cells. More particularly, the present invention provides methods of treating neurodegenerative disorders by administering umbilical cord blood cells and a substance capable of permeabilizing the blood brain barrier. In one embodiment, the blood brain barrier permeabilizer is mannitol. In another embodiment, the blood brain barrier permeabilizer is Cereport.

The invention belongs to the technical field of medication, and in particular relates to a pemetrexed disodium freeze-dried powder injection and a preparation method thereof. The pemetrexed disodium freeze-dried powder injection consists of pemetrexed disodium and mannitol, wherein the mass ratio of the mannitol to the pemetrexed disodium is (0.6-2.0):1. The preparation method comprises the following steps: adding injecting water into a liquid preparation tank; adding the pemetrexed disodium weighted according to the formula; stirring until the pemetrexed disodium completely dissolved; adding the mannitol; regulating the pH by utilizing a hydrochloric acid solution or a sodium hydroxide solution; adding activated carbon for decoloration; filtering to remove the carbon; finely filtering with a filter membrane; subpackaging; and freezing and drying. The pemetrexed disodium freeze-dried powder injection has excellent moldability; the appearance of the solution before freezing is clear; the frozen and dry product has good re-dissolubility; and the re-dissolved product has the advantages of good clarity, low impurity content, low moisture content, good stability and controllable quality.

The invention provides a cassia obtusifolia tea bag with functions of weight reduction, hypotension and hypoglycemic effect, which is characterized in that the production process comprises the following steps: washing, cleaning and drying the cassia obtusifolia stem, leaf and grain, crushing by a pulverizer to 280 meshes, uniformly stirring, packing, disinfecting to obtain the cassia obtusifolia tea bag with functions of lipid lowering, hypotension and hypoglycemic effect. The optimal composition and the weight part ratio of the tea bag are: 40-60 parts of dried cassia obtusifolia stem, leaf and grain, 10 parts of dried lotus leaf, 5 parts of haw, 5 parts of dried balsam pear, 5 parts of Chinese wolfberry, 10 parts of Pu'er tea, 10 parts of cassia seed, 5 parts of mulberry leaf, 5 parts of folium apocyni veneti, 5 parts of Chinese yam as medicine, 3 parts of rhubarb, 2 parts of chrysanthemum, 2 parts of honeysuckle flower, 1 part of boat-fruited sterculia, 5 parts of cassia seed, 5 parts of kudzu root and 10 parts of additive. The additive is composed of fatty acid sucrose ester, xylitol, mannitol crystal, natural menthol, citric acid, trisodium phosphate, sodium saccharin and steviosid; the above components are carried out the processes of crushing, mixing, uniformly stirring, packing and disinfecting to obtain the tea bag.

The invention provides a Chinese herbal medicine feed additive capable of improving the immunity. The Chinese herbal medicine feed additive is characterized by comprising the following raw materials: willow herb, red-backed vegetable, Chinese yam, herba epimedii, jiaoshen yeast, caulis spatholobi, puerarin, cimicifugae foetidae, Chinese herbaceous peony, jian yeast, rheum officinale, mangnolia officinalis, cyrtomium fortunei, liquorice, radix scutellariae, honeysuckle stem, gynostemma pentaphylla, fuling, soy isoflavone, soyasaponin and additional components, wherein the additional components comprise vitamin A, vitamin B, vitamin C, chromium trichloride, huanyuan gel, xylitol and mannitol crystals according to the proportion of 0.2:0.2:0.5:0.3:1:1:1. The Chinese herbal medicine feed additive can replace antibiotics and medicines and has no toxic and side effects; the immunity of animals such as pigs, chicken and ducks can be obviously improved; relatively high economical benefits can be achieved with relatively small investment; antibiotic and chemical medicine residues are avoided; and an effective way is supplied to reducing the antibiotic residues in animal products.

The invention provides a preserved fruit without additive sugar which is prepared by the steps of selecting fruits, gum dipping, boiling in sugar, sugar dipping and baking, etc., and has the advantage that cane sugar and syrup in traditional technique are replaces by xylitol, sorbierite, maltitol or mannite, etc. Not only the sugar content of the product obtained by the invention is low and is lower than 30 percent but also the product has the advantages of abundant nourishment, unique flavor and good taste, which is suitable for wide crowd and especially for the special crowd of diabetics, etc.

The invention provides, among other things, lyophilized compositions of high surface area that comprise a protein and that reconstitute quickly and efficiently to solution of high protein concentration with minimal formation, if any, of foam, effervescence, bubbles, turbidity, or particulates that might be deleterious. The invention also provides, among other things, methods for making the lyophilized compositions. The invention in additional aspects also provides Raman Imaging Spectrographic methods for real time analyses of polymorphs in a sample using PLS algorithms. By way of particular example, the use of the method for the analysis of mannitol polymorphs is described, and the use of the analysis to determine optimum compositions and lyophilization methods for producing lyophilates of pharmaceutical proteins having a predefined distribution of mannitol polymorphs and having the aforementioned reconstitution properties is also described.

The invention discloses a preparing method and application of a human mesenchymal stem cell-sourced exosome beautifying preparation. The beautifying preparation comprises 92-108 parts of human umbilical cord mesenchymal stem cell exosome, 8-13 parts of mannitol, 0.42-0.55 part of oligopeptide-32, 1.3-2.5 parts of tetrapeptide-4, 0.7-1.3 parts of palmitoyl tripeptide-1 and 0.8-1.2 parts of palmitoyl pentapeptide-4. The preparation method includes: evenly mixing and stirring the human mesenchymal stem cell exosome, the mannitol, the oligopeptide-32, the tetrapeptide-4, the palmitoyl tripeptide-1and the palmitoyl pentapeptide-4 according to the weight, filtering through a filter membrane, performing split charging, and performing freeze drying to obtain the human mesenchymal stem cell-sourced exosome beautifying preparation. The exosome beautifying preparation can be externally applied to the epidermal layer or guided into an epidermis deep layer and the corium layer through a microneedle, a rolling needle or a hydro-lifting needle. The ImmuReg technology is utilized to bring the optimal repairing effect of freeze-dried powder into play, the skin immune state can be precisely adjusted, and accordingly aged cells can be removed, and skin cells can be rejuvenated.

The invention relates to a liraglutide sustained-release micro sphere preparation and a preparation method thereof. The liraglutide sustained-release microsphere preparation comprises 5mg to 100mg of liraglutide, 0.5mg to 10mg of a protective agent and 50mg to 1000mg of a polylactic acid-glycolic acid copolymer, wherein the protective agent is one or a mixture of a plurality of sucrose, mycose, gelatin, mannitol, glycine, lysine and human serum albumin; the molecular weight of the polylactic acid-glycolic acid copolymer is 5000-20000 Daltons, and the ratio of polylactic acid to glycolic acid in the polylactic acid-glycolic acid copolymer is 1:3 to 3:1. According to the liraglutide sustained-release microsphere preparation disclosed by the invention, regular microspheres and medicines uniformly distributed in the microspheres can be obtained by just emulsifying and volatizing an organic solvent; processing procedures are simple; operation is simple; good repeatability is realized in preparation; the prepared liraglutide sustained-release microsphere preparations in batches have no remarkable difference; the obtained microspheres are uniform in grain size, narrow in distribution, controllable in grain size, round and orderly in surfaces and low in burst release rate.

The invention belongs to the technical field of medicine preparation, and particularly relates to a freeze-drying protection system required for a nucleic acid amplification reagent and a preparationmethod of the freeze-drying protection system. The freeze-drying protection system comprises the nucleic acid amplification reagent and a freeze-drying protection additive, wherein the nucleic acid amplification reagent is a reagent used for LAMP reaction amplification, the freeze-drying protection additive is one or a compound of the following reagents: polyethylene glycol, mannitol, polyvinylpyrrolidone, glucan, trehalose, sucrose, bovine serum albumin, collagen, threonine and glycine, and the concentration of the weight-to-volume ratio of the freeze-drying protection additive and the amplification reaction reagent is 3% to 25%. The freeze-drying protection additive used in the invention has the advantages of small volume, short freeze-drying time, high efficiency and low energy consumption, and the freeze-drying protection system can be directly used for gene chip experiments, does not cause repeated freeze-thaw and waste of reagents, and can effectively ensure the activity of active substances in the freeze-drying process.

The invention discloses a medicament formula for relieving pain caused by infusion medicament and preventing phlebitis. The medicament formula can be used for relieving pain caused by intravenous supplementing potassium, infusion mannitol, azithromycin, fructose diphosphate sodium and chemotherapeutic medicaments, and can be used for effectively preventing and treating extravasation phlebitis caused by long-term use of a remaining needle, infusion of vein high-nutrition medicaments, infusion of chemotherapeutic medicaments, infusion extravasation and the like. According to the medicament formula, 20-35ng of anisodamine, 6-13ml of lidocaine, 15-26mg of dexamethasone and 4-6ml of glycerin are arranged in a sterile kidney basin, sterile gauze is coated above a puncture part after being uniformly wetted, and an external preservative film is wound on the gauze. The medicinal formula has the advantages of continually and efficiently relieving local pain caused by infusion medicaments, and effectively preventing and treating local inflammation, swelling pain and stripped cable change caused by infusion.

The invention relates to a method for preparing fruit/vegetable or cereal or medicine-food homologous ferment health-care foods by using probiotics fermentation. According to the method, inventors disclose strains, which are applicable to the production of ferments by taking fruits/vegetables or cereals or medicine-food homologous food materials as fermentation raw materials, and optimize a fermentation process, ferment fermented stock solutions of the fruits/vegetables or cereals or medicine-food homologous food materials or the like are obtained, and various ferment products are obtained through subsequent processing. Obtained ferments are rich in functional components, i.e., exopolysaccharides, mannitol and SOD accumulated during fermentation, thereby being ideal health-care foods.

The invention belongs to the field of traditional Chinese medicines or healthcare foods, relates to a dendrobium preparation, and in particular relates to dendrobium buccal tablets. The formula of the dendrobium buccal tablets is composed of dendrobium ultra-fine powder, mannitol, white granulated sugar powder, magnesium stearate, aerosol, citric acid, borneol/menthol, mint oil and mint essence, wherein under the formula aforementioned, wet granulation is performed, and then tabletting is performed to prepare the buccal tablets; and the dendrobium buccal tablets prepared by the formula are high in bioavailability and good in taste. Additionally, the invention further discloses a preparation process for dendrobium ultra-fine powder. The preparation process specifically comprises the following steps of: peeling the cleaned fresh dendrobium bars; drying and slicing to achieve a thickness of not greater than 1 mm; and performing drying treatment at 50-60 DEG C to cause the water content to be 2-3%, and crushing for 10-30 minutes by an ultra-fine crusher, so as to obtain the dendrobium ultra-fine powder. According to the process, the loss rate of the precious medicine of dendrobium is further reduced by optimizing the slice thickness and omitting the step of processing crude powder.

A liposome of breviscapine for preparing the medicines to cure cerebral thrombus and coronary heart disease is prepared from breviscapine, phosphatide, cholesterol, and supporting agent chosen from sorbitol, mannitol, cane sugar, sodium chloride, water-soluble starch, etc by different methods. Its advantages are high absorption rate, high biologic utilization rate, and high stability.

The invention discloses a vaccine cryoprotectant without composition of gelatin and human albumin. The vaccine cryoprotectant comprises dextran (40), cane sugar, lactose, mannitol, glycine, arginine, sodium glutamate, urea and 199 synthetic medium. The invention does not contain ingredients of animal origin and the content of endotoxin of vaccine is greatly decreased, thus irritation and harm to a human body are greatly decreased and the vaccine has better safety and stability. Meantime, the cryoprotectant disclosed by the invention does not contain expensive raw materials such as trehalose and the like, thus the cryoprotectant has the advantage of low cost and is more applicable to industrialization.

This invention relates to aluminum electrolytic capacitor and its preparation method, especially relates to aluminum electrolytic capacitor used in flashing light and its preparation method. Its work electrolyte components is that main solvent is ethylene glycol. Secondary solvent is one or mixture N.N dimethyl formamide, N-methyl-2- pyrrolidone, polyethylene glycol octyl phellyl ether and water. The main solute is one or mixture of ammonium benzoate, ammonium sebacate, ammonium pentaborate, azelaic acid hydrogen ammonium, dodecandioic acid ammonium, mannitol. The additive is one of mixture of m-dinitrobenzene, ammonium dibasic phosphate, nitrodracylic acid ammonium and amphi nitryl benzoic alcohol. The capacitor in this invention is good in pressure resistance, the leakage current is little, the slow leakage rally can be used to make flashing light aluminum electrolytic capacitor of rated voltage keep around 330V.

The invention relates to a pantoprazole sodium freeze-dried powder injection and a preparation method thereof. The powder injection is prepared from pantoprazole sodium and mannitol, wherein the consumption ratio of the pantoprazole sodium to the mannitol is (1:0.8)-(1:1.6), and the PH value is 10.5-11.0. In the invention, by lowering the pre-freezing temperature, properly lowering the freezing temperature, maintaining the lowered freezing temperature for a proper time, properly shortening two-stage drying time and carrying out other adjustment processes, good appearance and quality of the product can be kept under the condition that the content of the mannitol is low, the processes are reliable and feasible, and the effect is obvious. The prepared product has low content of related substances and has controllable quality, and the freeze-dried product has good clarity and formability after being redissolved.